Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,451 | 1,555 | 3,640 | 5,906 | 5,022 |
| Receivables | 1,294 | 1,294 | 1,315 | 224 | 226 |
| TOTAL | $4,941 | $3,100 | $5,472 | $6,755 | $5,936 |
| Non-Current Assets | |||||
| PPE Net | 268 | 287 | 280 | 320 | 357 |
| Intangibles | 65,195 | 65,195 | 65,195 | 65,195 | 65,195 |
| Other Non-Current Assets | 53,936 | 53,936 | 53,936 | 148,631 | 148,660 |
| TOTAL | $119,399 | $119,418 | $119,411 | $214,146 | $214,212 |
| Total Assets | $124,340 | $122,518 | $124,883 | $220,901 | $220,148 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,093 | 1,121 | 563 | 1,243 | 1,514 |
| Other current liabilities | 707 | 905 | 1,476 | 1,907 | 1,869 |
| TOTAL | $1,800 | $2,026 | $2,039 | $3,150 | $3,383 |
| Non-Current Liabilities | |||||
| TOTAL | $20,504 | $20,509 | $20,525 | $49,929 | $49,932 |
| Total Liabilities | $22,304 | $22,535 | $22,564 | $53,079 | $53,315 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,520 | 60,520 | 59,476 | 59,479 | 58,664 |
| Common Shares | 727 | 714 | 24 | 714 | 704 |
| Retained earnings | -140,981 | -139,978 | -137,430 | -71,676 | -69,795 |
| TOTAL | $102,036 | $99,983 | $102,319 | $167,822 | $166,833 |
| Total Liabilities And Equity | $124,340 | $122,518 | $124,883 | $220,901 | $220,148 |